Skip to main content
Clinical Trials/NCT06241092
NCT06241092RecruitingNot Applicable

AI-Based Multimodal Multi-tasks Analysis Reveals Tumor Molecular Heterogeneity, Predicts Preoperative Lymph Node Metastasis and Prognosis in Papillary Thyroid Carcinoma: A Retrospective Study

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1 site in 1 country256 target enrollmentStarted: April 1, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
256
Locations
1
Primary Endpoint
Lymph node metastasis

Study Overview

Brief Summary

This study involved a comprehensive analysis of 256 PTC patients from Sun Yat-sen Memorial Hospital of Sun Yat-sen University (SYSMH) and 499 patients from The Cancer Genome Atlas. DNA-based next-generation sequencing (NGS) and single-cell RNA sequencing (scRNA-seq) were employed to capture genetic alterations and TME heterogeneity. A deep learning multimodal model was developed by incorporating matched histopathology slide images, genomic, transcriptomic, immune cells data to predict LNM and disease-free survival (DFS).

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Cross Sectional

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • ≥ 18 years of age Diagnosis of Papillary thyroid carcinoma at least one months before trial Willing to return for required follow-up (posttest) visits

Exclusion Criteria

  • The patient requires valve or other likely surgery The patient is unable to carry out any physical activity without discomfort The patient had thyroid ache within three months prior to enrollment The patient refuses to give informed consent The patient is a candidate for coronary bypass surgery or something similar

Outcomes

Primary Outcomes

Lymph node metastasis

Time Frame: 2021.10.1

Lymph node metastasis is frequently influenced by a myriad of factors, and tumor heterogeneity stands out as a significant contributing element.

Secondary Outcomes

  • Disease-free survival(2021.10.1)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Yunfang Yu

Dr.

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Study Sites (1)

Loading locations...

Similar Trials

AI-Based Multimodal Multi-tasks Analysis... | Clinical Trial